FDA Releases Report to Congress Regarding CBD
![Cannabis Law (leaf)](/sites/default/files/styles/fullscreen_4x3_767x575_1x/public/2024-07/Cannabis%20Law%20%28Tertiary%29%20%281%29.jpg?itok=QI0GLGft)
Yesterday, the FDA belatedly released a report in its progress towards CBD enforcement, as required by Congress.
Although the report repeats the FDA's concerns regarding CBD safety, and fails to offer a useful timeline for a reasonable regulatory pathway for the CBD market, it also affirms a desire for a nuanced "risk-based" approach to CBD enforcement.
Read the full article for a review of the report and insights on what CBD businesses need to know.
Print and share
Authors
Explore more in
Consumer Protection Review
Consumer Protection Review helps businesses that market and sell to consumers navigate federal and state legal issues related to advertising, privacy, promotions, products liability, government investigations, unfair competition, class actions and general consumer protection. Subscribe 🡢